John Yeakel, M., Aarthi Kannan, B., Nicole Hook Rattigan, P., Maki Yamamoto, M., Alexey Aleshin, M., Jeremy P. Harris, M., MD, & Ling Gao, M. (2021). Bespoke circulating tumor DNA as a biomarker for treatment response in a refractory Merkel cell carcinoma patient. Elsevier.
Style de citation Chicago (17e éd.)John Yeakel, MD, BA Aarthi Kannan, PhD Nicole Hook Rattigan, MD Maki Yamamoto, MD Alexey Aleshin, MPhil Jeremy P. Harris, MD, et MD Ling Gao. Bespoke Circulating Tumor DNA as a Biomarker for Treatment Response in a Refractory Merkel Cell Carcinoma Patient. Elsevier, 2021.
Style de citation MLA (8e éd.)John Yeakel, MD, et al. Bespoke Circulating Tumor DNA as a Biomarker for Treatment Response in a Refractory Merkel Cell Carcinoma Patient. Elsevier, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.